Publication:
Pathophysiology of als: What and how much do we know? [Als patofi̇zyoloji̇si̇: Neyi̇, ne kadar bi̇li̇yoruz?]

dc.contributor.authorsUluç K., Işak B., Tanridaǧ T., Us Ö.
dc.date.accessioned2022-03-28T14:55:12Z
dc.date.accessioned2026-01-11T11:39:22Z
dc.date.available2022-03-28T14:55:12Z
dc.date.issued2008
dc.description.abstractAmyotrophic lateral sclerosis is a progressive neurodegenerative disorder, primarily involving motor neurons in the cerebral cortex, brainstem and spinal cord. Most cases are sporadic, although 5-10% are familial, with 10-20% being linked to mutations in the enzyme superoxide dismutase-1. The clinical and pathological features of familial and sporadic cases are strikingly similar. In this review, the proposed mechanisms underlying the pathophysiology of ALS are focused with a hypothetical integrative model.
dc.identifier.issn10191941
dc.identifier.urihttps://hdl.handle.net/11424/256224
dc.language.isotur
dc.relation.ispartofMarmara Medical Journal
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectALS
dc.subjectHypothetical integrative model
dc.subjectPathophysiology
dc.titlePathophysiology of als: What and how much do we know? [Als patofi̇zyoloji̇si̇: Neyi̇, ne kadar bi̇li̇yoruz?]
dc.typereview
dspace.entity.typePublication
oaire.citation.endPage111
oaire.citation.issue1
oaire.citation.startPage102
oaire.citation.titleMarmara Medical Journal
oaire.citation.volume21

Files